A proof-of-concept study on the genomic evolution of sars-cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients

HIGHLIGHTS

• who: Claudia Alteri from the Department University of have published the research: A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-nau00efve patients, in the Journal: (JOURNAL) of 27/04/2022
• how: Are compared with the SARS-CoV-2 evolution observed in drug-nau00efve individuals. The same data were obtained at 4 comparable time points for the 5 drug-naive individuals (Supplementary Fig 1). This study was conducted in accordance with the principles of the 1964 Declaration of Helsinki.
• future: In vitro . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.